Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combination of multivalent DR5 receptor clustering agonists and histone deacetylase inhibitors for treatment of colon cancer

Journal of Controlled Release(2024)10.1016/j.jconrel.2024.10.062Source: DataRank Database

Combination of multivalent DR5 receptor clustering agonists and histone deacetylase inhibitors for treatment of colon cancer is a research paper published in Journal of Controlled Release (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.60)OA: greenTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Jaden Arnold,Monika Sima ORCID,Hasan Al Faruque ORCID,Jacob Galang,Sophia Hu-Lieskovan

Live enrichment

PubMed:39489464 PMC:PMC11611603 OpenAlex:https://openalex.org/W4404052316

University of Utah

Grant: P30 CS042014

National Cancer Institute

Grant: RO1 CA246716

NCI NIH HHS

Grant: P30 CA042014

NCI NIH HHS

Grant: R01 CA246716

National Institutes of Health

FWCI

1.60

Citation Percentile

0.8%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11611603/pdf/nihms-2034706.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0168365924007351?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168365924007351?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11611603/

Fields of Study

Histone Deacetylase Inhibitors ResearchCancer Treatment and PharmacologyPeptidase Inhibition and AnalysisMedicineChemistry

MeSH Terms

AcrylamidesAnimalsAntineoplastic AgentsColonic NeoplasmsHumansMice, NudeApoptosisCell Line, TumorReceptors, TNF-Related Apoptosis-Inducing LigandTNF-Related Apoptosis-Inducing LigandHistone Deacetylase Inhibitors

Keywords

Histone deacetylaseColorectal cancerCancerCancer researchReceptorChemistryPharmacologyHistoneMedicineBiochemistryInternal medicineGeneApoptosisDeath receptor 5Receptor ClusteringHpma CopolymerTrail Mimicking Peptides

Sustainable Development Goals

SDG 0: Good health and well-being